<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(3)</volume><submitter>Friedrich K</submitter><pubmed_abstract>&lt;h4>Background aims&lt;/h4>Primary sclerosing cholangitis predominantly affects males and is an important indication for liver transplantation. The rs738409 variant (I148M) of the PNPLA3 gene is associated with alcoholic and non-alcoholic liver disease and we evaluated its impact on the disease course of PSC.&lt;h4>Methods&lt;/h4>The I148M polymorphism was genotyped in 121 German PSC patients of a long-term prospective cohort and 347 Norwegian PSC patients.&lt;h4>Results&lt;/h4>In the prospective German cohort, actuarial survival free of liver transplantation was significantly reduced for I148M carriers (p = 0.011) compared to wildtype patients. This effect was restricted to patients with severe disease, as defined by development of dominant stenosis (DS) requiring endoscopic intervention. DS patients sh</pubmed_abstract><journal>PloS one</journal><pagination>e58734</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3591368</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A frequent PNPLA3 variant is a sex specific disease modifier in PSC patients with bile duct stenosis.</pubmed_title><pmcid>PMC3591368</pmcid><pubmed_authors>Stiehl A</pubmed_authors><pubmed_authors>Gotthardt DN</pubmed_authors><pubmed_authors>Runz H</pubmed_authors><pubmed_authors>Schemmer P</pubmed_authors><pubmed_authors>Brune M</pubmed_authors><pubmed_authors>Sauer P</pubmed_authors><pubmed_authors>Stremmel W</pubmed_authors><pubmed_authors>Friedrich K</pubmed_authors><pubmed_authors>Karlsen TH</pubmed_authors><pubmed_authors>Weiss KH</pubmed_authors><pubmed_authors>Schirmacher P</pubmed_authors><pubmed_authors>Rupp C</pubmed_authors><pubmed_authors>Hov JR</pubmed_authors><pubmed_authors>Steinebrunner N</pubmed_authors><pubmed_authors>Schaefer PK</pubmed_authors></additional><is_claimable>false</is_claimable><name>A frequent PNPLA3 variant is a sex specific disease modifier in PSC patients with bile duct stenosis.</name><description>&lt;h4>Background aims&lt;/h4>Primary sclerosing cholangitis predominantly affects males and is an important indication for liver transplantation. The rs738409 variant (I148M) of the PNPLA3 gene is associated with alcoholic and non-alcoholic liver disease and we evaluated its impact on the disease course of PSC.&lt;h4>Methods&lt;/h4>The I148M polymorphism was genotyped in 121 German PSC patients of a long-term prospective cohort and 347 Norwegian PSC patients.&lt;h4>Results&lt;/h4>In the prospective German cohort, actuarial survival free of liver transplantation was significantly reduced for I148M carriers (p = 0.011) compared to wildtype patients. This effect was restricted to patients with severe disease, as defined by development of dominant stenosis (DS) requiring endoscopic intervention. DS patients sh</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013</publication><modification>2026-04-08T03:49:22.967Z</modification><creation>2026-04-07T21:37:48.181Z</creation></dates><accession>S-EPMC3591368</accession><cross_references><pubmed>23505555</pubmed><doi>10.1371/journal.pone.0058734</doi></cross_references></HashMap>